Medical News

RSS

Vitamin Shoppe's first-quarter net sales increases by 11.0% to $19.1 million

Vitamin Shoppe, Inc., a leading specialty retailer and direct marketer of nutritional products, today announced its preliminary results for its fiscal first quarter ended March 27, 2010.

21 Apr 2010

St. Jude Medical reports 11% increase in first-quarter 2010 net sales

St. Jude Medical, Inc. today reported sales and net earnings for the first quarter ended April 3, 2010.

21 Apr 2010

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott today announced financial results for the first quarter ended March 31, 2010.

21 Apr 2010

Path to Progress 5K Run/Walk to be hosted to benefit ABTA's research and patient-family programs

The American Brain Tumor Association will again host its annual Path to Progress 5K Run/Walk on Saturday, May 22, 2010 at Soldier Field in Chicago.

21 Apr 2010

Study helps understand molecular mechanism underlying taurine's protection against hepatic fibrosis

Hepatic fibrosis (HF) occurs in most types of chronic liver diseases and approximately 25%-40% of HF cases may ultimately progress to hepatic cirrhosis. Hepatic stellate cells (HSCs) contribute significantly to the occurrence of HF and the activation of HSC is the key issue in the pathogenesis of HF. Taurine is a kind of important anti-injury substance in the body.

21 Apr 2010

IP Advocate founder settles long-standing legal battle with UGARF

In a move that positions IP Advocate for its next chapter as a champion of research translation, founder Dr. Renee Kaswan today announced that she has settled her long-standing legal battle with the University of Georgia Research Foundation.

21 Apr 2010

Inovio Biomedical wins Vaccine Industry Excellence Award in “Best Early Stage Biotech” category

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company was awarded a Vaccine Industry Excellence Award in the category of "Best Early Stage Biotech" by a panel of judges composed of a broad selection of biotech industry stakeholders. The award was presented at the World Vaccine Congress being held April 19 - 22, 2010, in Washington, D.C.

21 Apr 2010

Identity Force releases Spring 2010 National Survey of Hospital Compliance Executives

Identity Force today released its Spring 2010 National Survey of Hospital Compliance Executives. More than 200 compliance executives from AHA member hospitals in 43 states indicated data breaches and medical identity theft continue to grow despite new regulations like the Red Flag Rules and the HITECH Act, designed to protect against the theft and loss of personal information.

21 Apr 2010

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

21 Apr 2010

New method to analyze molecular activity of cancer drugs for solid tumors using skin biopsies

A research team today reported clinical results of a new method for analyzing the molecular activity of cancer drugs for solid tumors using skin biopsies. The approach, enabled by Cambridge Research & Instrumentation, Inc.'s imaging and analysis systems, was presented in a poster session at the American Association of Cancer Research's Annual Meeting in Washington D.C.

21 Apr 2010

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

21 Apr 2010

Preclinical data of ANG1005 and ANG1007 for treatment of brain cancer presented at AACR 2010

Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier through LRP-1 targeting, announced today that preclinical data was presented on two of its oncology programs, ANG1005 and ANG1007, for the treatment of brain cancers at the 101st Annual meeting of the American Association for Cancer Research 2010, April 17-21, in Washington, DC.

21 Apr 2010

CUPE to fight Liberals' patient-based funding model

Predictions that setting prices and tendering for the provision of hospital clinical services would lead to privatization of those services were reinforced by the Ministry of Health on Monday. A Ministry of Health spokesperson, in an email to the Thunder Bay Chronicle-Herald stated that the government is "not considering outsourcing or privatization" and that any change in that position "would only be undertaken with consultation with the field and that implementation would be phased in to protect hospitals and the public from service disruption."

21 Apr 2010

BankAtlantic to join the families of Miami-Dade County in battle against cancer

BankAtlantic, Florida's Most Convenient BankSM announced today that it will join the families of Miami-Dade County in the battle against cancer. The 2010 American Cancer Society Relay for Life of Hialeah, also known as Relevo Por La Vida - Hialeah, gets underway Saturday, April 24, 2010 with teams of residents gathering at The City of Hialeah: Goodlet Park, located at 4200 West 8th Avenue in Hialeah.

21 Apr 2010

Study assesses use of eMedonline to help manage patients' compliance with Gleevec

A clinical study underway at Rex Cancer Center of Wakefield will evaluate the use of telemonitoring in managing administration of Gleevec, a drug developed and manufactured by Novartis to treat chronic myeloid leukemia.

21 Apr 2010

Investment report on Array BioPharma

MicroStockProfit.com announces an investment report featuring Array BioPharma Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Apr 2010

French Ministry of Research grants French R&D tax credit accreditation to Cyprotex

Cyprotex, the drug discovery technology and information company, is pleased to announce that it has received French research tax credit approval for years 2009 through to 2011.

21 Apr 2010

Early tracheotomy does not reduce risk of VAP in mechanically ventilated adult ICU patients

Adult ICU patients who received tracheotomy 6 to 8 days vs. 13 to 15 days after mechanical ventilation did not have a significant reduction in the risk of ventilator-associated pneumonia, according to a study in the April 21 issue of JAMA.

21 Apr 2010

Staff, students join hands outside LSTM to mark World Malaria Day

One hundred staff and students joined hands outside Liverpool School of Tropical Medicine (LSTM) today to mark World Malaria Day, each person symbolising 10,000 of the lives lost every year to malaria.

21 Apr 2010

Touch Bionics wins Queen's Awards for Enterprise in Innovation category for 2010

Touch Bionics, developer of advanced upper-limb bionic technologies, today announced it is a winner of the prestigious Queen's Awards for Enterprise with an award in the Innovation category for 2010. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance.

21 Apr 2010

Medical News

Vitamin Shoppe's first-quarter net sales increases by 11.0% to $19.1 million

St. Jude Medical reports 11% increase in first-quarter 2010 net sales

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Path to Progress 5K Run/Walk to be hosted to benefit ABTA's research and patient-family programs

Study helps understand molecular mechanism underlying taurine's protection against hepatic fibrosis

IP Advocate founder settles long-standing legal battle with UGARF

Inovio Biomedical wins Vaccine Industry Excellence Award in “Best Early Stage Biotech” category

Identity Force releases Spring 2010 National Survey of Hospital Compliance Executives

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

New method to analyze molecular activity of cancer drugs for solid tumors using skin biopsies

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Preclinical data of ANG1005 and ANG1007 for treatment of brain cancer presented at AACR 2010

CUPE to fight Liberals' patient-based funding model

BankAtlantic to join the families of Miami-Dade County in battle against cancer

Study assesses use of eMedonline to help manage patients' compliance with Gleevec

Investment report on Array BioPharma

French Ministry of Research grants French R&D tax credit accreditation to Cyprotex

Early tracheotomy does not reduce risk of VAP in mechanically ventilated adult ICU patients

Staff, students join hands outside LSTM to mark World Malaria Day

Touch Bionics wins Queen's Awards for Enterprise in Innovation category for 2010

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News